Docoh
Loading...

PBLA Panbela Therapeutics

Filed: 11 Aug 21, 4:16pm

Exhibit 32.2

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Susan Horvath, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)

 

the Quarterly Report on Form 10-Q of Panbela Therapeutics, Inc. for the quarter ended June 30, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

   

(2)

 

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Panbela Therapeutics, Inc.

 

Dated: August 11, 2021

 

 

 

/s/ Susan Horvath

 

Susan Horvath

 

Chief Financial Officer

 

(Principal Financial Officer and Principal

 

Accounting Officer)